NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹365 Cr | ₹262 Cr | ₹216 Cr | ₹194 Cr | ₹98 Cr |
What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹262 Cr |
| Mar2023 | ₹216 Cr |
| Mar2022 | ₹194 Cr |
| Mar2013 | ₹98 Cr |
How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹365 Cr | 39.19 | |
| Mar2024 | ₹262 Cr | 21.26 | |
| Mar2023 | ₹216 Cr | 11.40 | |
| Mar2022 | ₹194 Cr | 98.02 | |
| Mar2013 | ₹98 Cr | - | |
Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹289.8 Cr | -3.5% | -5.7% | -9.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,827.6 Cr | -2.7% | -3.5% | -37.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,337.8 Cr | -2.6% | 6.2% | 14.7% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,385.0 Cr | -1% | 27.2% | 25.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹999.5 Cr | 8% | 6.5% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹469.6 Cr | 0.1% | -4.2% | -7.9% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.5% |
-5.7% |
-9.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses